Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 14;86(11):6665-6672.
doi: 10.1097/MS9.0000000000002458. eCollection 2024 Nov.

Effect of vitamin D supplementation on cardiovascular outcomes: an updated meta-analysis of RCTs

Affiliations
Review

Effect of vitamin D supplementation on cardiovascular outcomes: an updated meta-analysis of RCTs

Agha M W Mirza et al. Ann Med Surg (Lond). .

Abstract

Objective: To evaluate the effect of vitamin D supplementation on cardiovascular outcomes.

Methods: After searching different databases, we retrieved and included randomized controlled trials on long-term supplementation of vitamin D (≥1-year intervention) and reporting cardiovascular outcomes. We calculated risk ratio (RR) with 95% confidence intervals (CI) for dichotomous outcomes.

Results: Compared to the control group, the vitamin D group was not associated with a statistically significant decrease in the incidence of major adverse cardiovascular events (MACE) [risk ratio=0.99; 95% CI: 0.94-1.03]. We found no difference between the vitamin D group and the control group for the outcomes of incidences of myocardial infarction, heart failure, coronary revascularization, cardiovascular death, and all-cause mortality. The heterogeneity was low for all outcomes.

Conclusion: According to our meta-analysis, vitamin D supplementation did not reduce major adverse cardiovascular events, other cardiovascular parameters, and all-cause mortality.

Keywords: cardiology; cardioprotective; cardiovascular; cardiovascular events; meta-analysis; vitamin D.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Figures

Figure 1
Figure 1
PRISMA 2020 flow chart. Flow chart of included and excluded trials. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Figure 2
Figure 2
Comparison of incidence of MACE between patients receiving vitamin D or control. IV, inverse variance. MACE, major adverse cardiovascular events.
Figure 3
Figure 3
Comparison of all-cause mortality between patients receiving vitamin D or control. IV, inverse variance.
Figure 4
Figure 4
Comparison of incidence of cardiovascular death between patients receiving vitamin D or control. IV, inverse variance.

References

    1. Cui A, Zhang T, Xiao P, et al. . Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: A pooled analysis of 7.9 million participants. Front Nutr 2023;10:1070808. - PMC - PubMed
    1. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003;89:552–572. - PubMed
    1. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004;79:362–371. - PubMed
    1. Kienreich K, Tomaschitz A, Verheyen N, et al. . Vitamin D and cardiovascular disease. Nutrients 2013;5:3005–3021. - PMC - PubMed
    1. Giovannucci E, Liu Y, Hollis BW, et al. . 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008;168:1174–1180. - PMC - PubMed

LinkOut - more resources